Where does Allergan Pharmaceuticals International Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Allergan Pharmaceuticals International Limited ranks #9,960 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Allergan Pharmaceuticals International Limited hold?

Allergan Pharmaceuticals International Limited holds 31 US utility patents granted between 2017 and 2025, spanning 21 technology areas.

What is Allergan Pharmaceuticals International Limited's Innovation Score?

Allergan Pharmaceuticals International Limited has an Innovation Score of 39.2 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Allergan Pharmaceuticals International Limited focus on?

Allergan Pharmaceuticals International Limited's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 28 patents, ranking #814 of 7,163 assignees active in that subclass. Grants appear in 21 CPC subclasses total.

Is Allergan Pharmaceuticals International Limited's patent grant rate increasing or decreasing?

Allergan Pharmaceuticals International Limited's recent grant velocity is +25% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Allergan Pharmaceuticals International Limited's patents?

Allergan Pharmaceuticals International Limited's patents average 14.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Allergan Pharmaceuticals International Limited

Q: How is the Allergan Pharmaceuticals International Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 31 granted patents across 21 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Allergan ranks #9,960 of 49,997 tracked US assignees by granted-patent volume, with 31 patents across 21 technology areas.

#9,960
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.2/100): 14.7
avg claims per patent: +25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9960 · Foreign Corporation #9,960 · 31 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 31 grants
UPPER-Q #9,960/49,997
PHOTO-FINISH Adams Mfg
CPC-FOCUS A61K · 21 areas
INNOV-THIN 39.2/100
CLAIMS-RICH 14.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Adams Mfg. Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Allergan’s 39.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.0 pts (31%) Velocity 2.2 pts (6%) Breadth 16.2 pts (41%) Claim depth 8.8 pts (22%)

Qualcomm Incorporated · highest

85
Allergan Pharmaceuti… · this assignee

39
API · near

39
Arkalumen · near

39
fischerwerke & KG · near

39
LM Wind Power US… · near

39
3D Lighting… · lowest

7

What this shows Allergan's Innovation Score is 39.2/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Allergan?

Each dot is one of Allergan’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Allergan’s own 14.7 claims/patent is at or below the 14.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Allergan vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Allergan's grants concentrate

Allergan Pharmaceuticals International Limited is a focused PatentsView assignee: 21 CPC subclasses with 90.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (6 grants) versus a trough of 1 in 2023. By volume, Allergan sits between Adams Mfg. Corp. and Anello Photonics, Inc..

Allergan's three-year grant acceleration

Allergan Pharmaceuticals International Limited shows 5 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Adams Mfg

31
Adshir

31
Advanced Bifurcat…

31
Advantest Test So…

31
Amer Sports Canada

31
Amzetta

31
Anchor Packaging

31
Anello Photonics

31
Allergan Pharmace… ◀

31

What this shows Allergan holds 31 patents at rank #9,965, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Allergan

By rank, the assignees closest to #9,965 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Allergan's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Allergan, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Allergan ranks #814 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

fischerwerke GmbH & Co. KG 39 API Corporation 39 Arkalumen Inc. 39 LM Wind Power US Technology APS 39

Allergan's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Allergan Pharmaceuticals International Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	3	9.7%
2018	4	12.9%
2019	5	16.1%
2020	6	19.4%
2021	4	12.9%
2023	1	3.2%
2024	4	12.9%
2025partial year	4	12.9%

Which technologies does Allergan Pharmaceuticals International Limited patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 28

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 24

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 5

C07K - Peptides 5

C12Y - Enzymes 3

B05D - Processes FOR Applying Fluent Materials TO Surfaces, IN General 2

C09D - Coating Compositions, e.g. Paints, Varnishes OR LACQUERS; Filling PASTES; Chemical Paint OR INK REMOVERS; INKS; Correcting FLUIDS; WOODSTAINS; Pastes OR Solids FOR Colouring OR PRINTING; USE OF Materials Therefor 2

C08B - POLYSACCHARIDES; Derivatives Thereof 2

C08H - Derivatives OF Natural Macromolecular Compounds 2

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 2

C08L - Compositions OF Macromolecular Compounds 2

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

C07D - Heterocyclic Compounds 1

Top 15 of 21 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Allergan Pharmaceuticals International Limited's patent record in context - here's where to go next.

Allergan Pharmaceuticals International Limited's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 90.3% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #9,960 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Allergan Pharmaceuticals International Limited against Adams Mfg. Corp., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.